Fresenius Medical Care
166 hedge funds and large institutions have $805M invested in Fresenius Medical Care in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 61 reducing their positions, and 34 closing their positions.
157% more call options, than puts
Call options by funds: $1.39M | Put options by funds: $540K
0.58% more ownership
Funds ownership: 10.44% → 11.01% (+0.58%)
7% less funds holding
Funds holding: 178 → 166 (-12)
22% less capital invested
Capital invested by funds: $1.03B → $805M (-$225M)
26% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 34
38% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 61
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pzena Investment Management
New York
|
+$47.8M |
| 2 |
Millennium Management
New York
|
+$20.1M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$11.7M |
| 4 |
Morgan Stanley
New York
|
+$7.58M |
| 5 |
Two Sigma Investments
New York
|
+$6.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$13.7M |
| 2 |
CI
Cambiar Investors
Denver,
Colorado
|
-$9.31M |
| 3 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
-$5.29M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$5.04M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.27M |
FMS Hedge Fund Activity: Q2 2022 in Review
166 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q2 2022, worth a combined $805M — down 22% from $1.03B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of FMS and 25 opened new positions — a net loss of 9 holders — while 61 trimmed existing stakes and 38 added.
The largest buyer was Pzena Investment Management, adding an estimated $47.8M. The largest seller was Citigroup, cutting an estimated $13.7M.
- 166 institutional investors held Fresenius Medical Care (FMS) as of Q2 2022, down from 178 in Q1 2022.
- Funds reported $805M of Fresenius Medical Care stock for Q2 2022, down 22% quarter-over-quarter.
- 25 funds opened new Fresenius Medical Care positions in Q2 2022 and 34 closed out, a net change of -9 holders.
- The largest Fresenius Medical Care buyer in Q2 2022 was Pzena Investment Management, an estimated $47.8M added.
- The largest Fresenius Medical Care seller in Q2 2022 was Citigroup, an estimated $13.7M sold.
Based on aggregated 13F filings for Q2 2022.